Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BIK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HLA-DRB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPINT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM101B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPCAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996809 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTBD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2BFXP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CENPV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM169A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEMIS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC6A15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPYL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTAG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on